touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Diagnosis and treatment of patients with Lennox–Gastaut syndrome

    touchPANEL DISCUSSION for touchNEUROLOGY

    Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage Lennox–Gastaut syndrome (LGS). Moderated by a leading European expert, this episode brings together faculty from the Gulf region and Japan, as they explore diagnostic approaches in their regions, before sharing their unique regional perspectives and real-world experience in caring for patients with LGS.  

    The experts

    • Prof. Nicola Specchio: Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
    • Dr Raidah Al-Baradie: King Fahad Specialist Hospital, Dammam, Saudi Arabia
    • Dr Taoufik Alsaadi: American Center for Neurology, Abu Dhabi, Dubai, UAE
    • Prof. Eiji Nakagawa: National Center of Neurology and Psychiatry, Tokyo, Japan
    • Prof. Hideo Yamanouchi: Saitama Medical University, Saitama, Japan

      • Chapters

      • The disease state of LGS (00:00–18:47)
      • Managing patients with LGS in the Gulf (18:48–37:00)
      • Managing patients with LGS in Japan (37:01–56:25)

        • This touchPODCAST is for HCPs outside of the UK only. 

        This activity is supported by an independent medical educational grant from Jazz Pharmaceuticals. 

        Jointly provided by Partners for Advancing Clinical Education and touchIME.

        touchIME is an EBAC® accredited provider.

        For further information visit: touchneurologyime.org/diagnosis-treatment-lennox-gastaut-syndrome/

        57 min
      • Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies

        touchEXPERT FOCUS for touchCARDIO

        Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophic cardiomyopathy to highlight existing gaps in patient care. They will then discuss the latest data for emerging therapeutic classes and consider how they may address patients’ unmet needs in the future.   

        The experts

        • Dr Martin Maron, Lahey Hospital & Medical Center, Burlington, MA, USA
        • Dr Michelle Michels, Erasmus MC, Rotterdam, The Netherlands

          • This touchPODCAST is for healthcare professionals outside of the UK.

          This activity is supported by an independent medical educational grant from Cytokinetics, Inc.

          Jointly provided by Partners for Advancing Clinical Education and touchIME.

          touchIME is an EBAC® accredited provider.

          For further information visit our website: 

          https://touchcardio.com/

          33 min
        • Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

          Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms

          touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY

          In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients.

          Course director

          Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA

          The clinical expert

          Prof. Nicholas Girard, Institut Curie, Paris, France

          This touchPODCAST is for HCPs only.

          This activity is funded by an educational grant from AstraZeneca Ltd. 

          This medical education is jointly provided by USF Health and touchIME.

          touchIME is an EBAC® accredited provider.

          For further information visit our website:  

          touchONCOLOGY: https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/

          touchRESPIRATORY: https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/

           

          31 min
        • Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

          touchEXPERT FOCUS for touchONCOLOGY


          Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.

          The expert:

          • Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium

            • This touchPODCAST is for HCPs outside of the UK.

            This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

            The activity is jointly provided by USF Health and touchIME.

            touchIME is an EBAC® accredited provider.

            For further information visit our website: www.touchONCOLOGY.com

            33 min
          • FCS unmasked: Closing gaps in diagnosis, treatment and patient support

            touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY

            Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They  also share key insights from their experience with novel targeted therapies for FCS.

            The expert(s)

            • Professor Antonio Gallo, Sorbonne University Hospital Pitié-Salpêtrière, Paris, France
            • Dr Vikesh Singh, Johns Hopkins University School of Medicine, Baltimore, MD, USA

              • This touchPODCAST is for HCPs in the USA and Europe only.

              This activity is funded by an independent medical education grant from Arrowhead Pharmaceuticals, Inc.

              This activity is jointly provided by USF Health and touchIME. 

              touchIME is an EBAC® accredited provider.


              For further information visit our websites: https://touchcardioime.org/fcs-unmasked/ and https://touchendocrinologyime.org/fcs-unmasked/

              36 min
            • Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics

              touchEXPERT FOCUS for touchHAEMATOLOGY

              Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the essential role of multidisciplinary support.

              The experts

              • Prof. Lucia de Franceschi, University of Verona, Italy

                • This touchPODCAST is for HCPs outside of the UK.

                This activity is funded by an independent medical education grant from Agios Pharmaceuticals, Inc.

                The activity is jointly provided by USF Health and touchIME.

                touchIME is an EBAC® accredited provider.

                For further information visit our website: www.touchHAEMATOLOGY.com

                39 min
              • Bridging diagnostic and therapeutic gaps in Fabry disease management

                touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY


                Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlations.

                The experts

                • Dr Raphael Schiffmann, Texas Christian University, Fort Worth, TX, USA
                • Ms Dawn Laney, Emory Genetic Clinical Trials Center, Atlanta, GA, USA
                • Dr Ozlem Goker-Alpan, Lysosomal Disorders Research and Treatment Center (LDRTC), Fairfax, VA, USA

                  • This touchPODCAST is for HCPs outside of the UK.


                  This activity is funded by an independent medical education grant from Amicus Therapeutics Inc.

                  This activity is jointly provided by USF Health and touchIME.

                  For further information visit our websites: 

                  www.touchENDOCRINOLOGY.com www.touchCARDIO.com and www.touchNEUROLOGY.com

                  40 min
                • Applying patient and disease characteristics to guide R/M NPC treatment

                  touchCASES for touchONCOLOGY

                  Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases.

                  The experts:

                  • Dr Nabil Saba, Winship Cancer Institute, Emory University, Atlanta, GA, USA
                  • Dr Victoria Villaflor, Chao Family Comprehensive Cancer Center, UCI Health, Orange, CA, USA

                    • This activity is for HCPs in the USA only

                    This activity is funded by an independent medical education grant from Coherus Biosciences.

                    This activity is jointly provided by USF Health and touchIME.

                    For further information visit our website: https://touchoncologyime.org/treatment-selection-in-r-m-npc/

                     

                    36 min
                  • Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

                    touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY

                    Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.

                    The experts

                    • Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
                    • Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
                    • Dr Francesca Gay, University of Torino, Italy

                      • This touchPODCAST is for HCPs outside of the USA.

                      This activity is funded by an independent medical education grant from GSK.


                      This activity is provided by touchIME.
                      touchIME is an EBAC® accredited provider.

                      For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com 

                      38 min
                    • Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes

                      touchEXPERT FOCUS for touchOPHTHALMOLOGY

                      Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice.

                      The experts:

                      • Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
                      • Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA
                      • Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA

                        • This touchPODCAST is for HCPs in the USA, Latin America and Canada only.

                        This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc.

                        The activity is jointly provided by USF Health and touchIME.


                        For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/

                         

                         

                        42 min

                      About touchPODCAST

                      From the publisher's feed

                      Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.